Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing

BioPharm Sponsored by Cytiva
  • Biopharma Trends
  • Upstream
  • Downstream
  • Regulatory/QbD

Articles

Subscribe to Enews Share This Page
Email Facebook Twitter

Cytiva Acquires Chromatography Resins Manufacturing Facility in M

…
August 26, 2022 - BioPharm


…

mRNA: the messenger
August 10, 2022 - Cytiva …

Challenges of scaling up buffer production for GMP and how to eva

…
August 10, 2022 - Cytiva


…

Cytiva expanding US operations
August 10, 2022 - Cytiva



…

Going Viral? Developing scalable viral vector manufacturing
August 10, 2022 - Cytiva



…

Do Modeling and Simulation Tools Really Benefit the Biosimilar In

…
July 28, 2022 - BioPharm
modeling and simulation

…

Recombinant Adeno-Associated Virus Type 5 Production Process
July 28, 2022 - Cytiva laboratory biopharma …

Working With Advanced Therapeutics: You Bring the Idea, We Bring

…
July 28, 2022 - Cytiva advanced therapy …

Developing a Robust Bioprocess Using Mechanistic Models
July 28, 2022 - Cytiva robust model …

Alkaline stability of Fc and VH3 binding in protein A resins
June 30, 2022 - Cytiva



In the developm

…

Previous PageNext Page

Related Content

  • Cytiva roadshow! Join our US and Canada OligoFest on 26 September in Marlborough, MA
  • Considerations for smarter and faster process development
  • Q&A: Oligonucleotide synthesis in process development and scale-up
  • Comparison of Three Different Screening Techniques for Predicting Step Elution Conditions for a Cation Exchanger
  • On-demand webcast: Introducing Supor Prime filters
Home | Biopharma Trends | Upstream | Downstream | Regulatory/QbD | Terms of Use | Privacy Policy | About Us
BioPharm International | Pharmaceutical Technology
© 2025 MJH Associates. All rights reserved.